Moderna and Merck announced successful results from the Phase III study of their personalized mRNA vaccine for melanoma in combination with the immunotherapy Keytruda, which could mean a revolution in cancer treatment by tailoring therapy to the genetic profile of the tumor, although detailed data from studies and regulatory approval are still lacking. (translated)
Merck and Moderna have achieved positive results in a clinical study for their mRNA vaccine against advanced skin cancer, which is considered a significant breakthrough in cancer therapy. (translated)
Eine internationale Studie zeigt, dass ein experimenteller mRNA-Grippeimpfstoff bei Erwachsenen über 50 Jahren 26,6 Prozent wirksamer ist als herkömmliche Impfstoffe, obwohl er auch mit höheren Nebenwirkungen verbunden ist. #mRNAImpfstoff #Grippeimpfung #Gesundheit
